Bicara Therapeutics Inc. Common Stock (BCAX) NASDAQ
20.00
+0.36(+1.83%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
20.00
+0.36(+1.83%)
Currency In USD
| Market Cap | 920.21M |
| Enterprise Value | 825.24M |
| P/E Ratio | -7.72 |
| PEG Ratio | 0.17 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.36 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -4.56 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.28 |
| Return On Equity | -0.36 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -155.6M |
| Net Income | -137.95M |
| Diluted EPS | -2.52 |
| Total Cash | 539.75M |
| Total Cash/Share | 8.89 |
| Total Debt | 1.44M |
| Total Debt/Equity | 0 |
| Current Ratio | 13.85 |
| Book Value Per Share | 8.46 |
| 52-Week Change | 79.21 |
| 52-Week High | 24.25 |
| 52-Week Low | 8.48 |
| Moving Average 50 Days | 21.48 |
| Moving Average 200 Days | 17.31 |
| Average Volume | 557,456 |
| Shares Outstanding | 54.78M |
| % Held by Institutions | 130.33 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |